Partial lipodystrophy
3 papers
- Humans1
Trial sponsors
1 trialPhase 232 people
Latest
2 in 12 monthsDiabetes, Obesity & Metabolism
Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real-Life Experience From a National Reference Network
Cohort study in peopleSGLT2 inhibitors
ADA Scientific Sessions 2026 Abstract
Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists Compared with Leptin in a Retrospective Study of Patients with Partial Lipodystrophy
Cohort study of 11 peopleGLP-1 receptor agonists
ENDO 2025 Abstract
MON-694 Resolving the Metabolic Puzzle, Tirzepatide's Multifaceted Benefits in Partial Lipodystrophy
Case reportTirzepatide
ADA Scientific Sessions 2025 Abstract
Why Some Patients Tolerate Severe Insulin Resistance Longer—Insights from Familial Partial Lipodystrophy
Cohort study of 253 peoplePopulations